Update on Melasma Treatments

키워드

참고문헌 (96)

1. Sarkar R, "Future therapies in melasma : what lies ahead?", Indian J Dermatol Venereol Leprol, 86, pp.8~17 (2020)
2. Kwon SH, "Heterogeneous pathology of melasma and its clinical implications", Int J Mol Sci, 17, pp.824~ (2016)
3. Handel AC, "Risk factors for facial melasma in women : a case-control study", Br J Dermatol, 171, pp.588~594 (2014)
4. Rajanala S, "Melasma pathogenesis: a review of the latest research, pathological findings, and investigational therapies", Dermatol Online J, 25, pp.25~ (2019)
5. Kang HY, "The dermal stem cell factor and c-kit are overexpressed in melasma", Br J Dermatol, 154, pp.1094~1099 (2006)
6. Kim M, "Senescent fibroblasts in melasma pathophysiology", Exp Dermatol, 28, pp.719~722 (2019)
7. Kang HY, "Transcriptional profiling shows altered expression of Wnt pathway-and lipid metabolism-related genes as well as melanogenesis-related genes in melasma", J Invest Dermatol, 131, pp.1692~1700 (2011)
8. Kim JY, "Reduced WIF-1 expression stimulates skin hyperpigmentation in patients with melasma", J Invest Dermatol, 133, pp.191~200 (2013)
9. Kim M, "Secreted frizzled-related protein 2(sFRP2)functions as a melanogenic stimulator; the role of sFRP2 in UV-induced hyperpigmentary disorders", J Invest Dermatol, 136, pp.236~244 (2016)
10. Kim JY, "siRNA-mediated knock-down of COX-2 in melanocytes suppresses melanogenesis", Exp Dermatol, 21, pp.420~425 (2012)
11. Lee DJ, "Pendulous melanocytes : a characteristic feature of melasma and how it may occur", Br J Dermatol, 166, pp.684~686 (2012)
12. Torres-Álvarez B, "Histochemical and immunohistochemical study in melasma : evidence of damage in the basal membrane", Am J Dermatopathol, 33, pp.291~295 (2011)
13. Na JI, "Effect of tranexamic acid on melasma : a clinical trial with histological evaluation", J Eur Acad Dermatol Venereol, 27, pp.1035~1039 (2013)
14. Siiskonen H, "Ultraviolet radiation and skin mast cells: Effects, mechanisms and relevance for skin diseases", Exp Dermatol, 27, pp.3~8 (2018)
15. Lee HJ, "Histamine receptor 2-mediated growth-differentiation factor-15 expression is involved in histamine-induced melanogenesis", Int J Biochem Cell Biol, 44, pp.2124~2128 (2012)
16. Yoshida M, "Histamine induces melanogenesis and morphologic changes by protein kinase A activation via H2 receptors in human normal melanocytes", J Invest Dermatol, 114, pp.334~342 (2000)
17. Iddamalgoda A, "Mast cell tryptase and photoaging : possible involvement in the degradation of extra cellular matrix and basement membrane proteins", Arch Dermatol Res, 300(Suppl 1), pp.S69~S76 (2008)
18. Coussens LM, "Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis", Genes Dev, 13, pp.1382~1397 (1999)
19. Kang WH, "Melasma : histopathological characteristics in 56 Korean patients", Br J Dermatol, 146, pp.228~237 (2002)
20. Parkinson LG, "Granzyme B mediates both direct and indirect cleavage of extracellular matrix in skin after chronic low-dose ultraviolet light irradiation", Aging Cell, 14, pp.67~77 (2015)
21. Kang HY, "In vivo reflectance confocal microscopy detects pigmentary changes in melasma at a cellular level resolution", Exp Dermatol, 19, pp.e228~e233 (2010)
22. Kim EH, "The vascular characteristics of melasma", J Dermatol Sci, 46, pp.111~116 (2007)
23. Lee SH, "Upregulation of protease-activated receptor-2 in keratinocytes by epidermal vascular endothelial growth factor in vitro and in vivo", Exp Dermatol, 26, pp.286~288 (2017)
24. Regazzetti C, "Endothelial cells promote pigmentation through endothelin receptor B activation", J Invest Dermatol, 135, pp.3096~3104 (2015)
25. Castanedo-Cazares JP, "Near-visible light and UV photoprotection in the treatment of melasma : a double-blind randomized trial", Photodermatol Photoimmunol Photomed, 30, pp.35~42 (2014)
26. Regazzetti C, "Melanocytes sense blue light and regulate pigmentation through opsin-3", J Invest Dermatol, 138, pp.171~178 (2018)
27. Boukari F, "Prevention of melasma relapses with sunscreen combining protection against UV and short wavelengths of visible light : a prospective randomized comparative trial", J Am Acad Dermatol, 72, pp.189~190 (2015)
28. Verallo-Rowell VM, "Visible light photopatch testing of common photocontactants in female filipino adults with and without melasma : a cross-sectional study", J Drugs Dermatol, 7, pp.149~156 (2008)
29. Arrowitz C, "Effective tyrosinase inhibition by thiamidol results in significant improvement of mild to moderate melasma", J Invest Dermatol, 139, pp.1691~1698 (2019)
30. Jimbow K, "Mechanism of depigmentation by hydroquinone", J Invest Dermatol, 62, pp.436~449 (1974)
31. Spencer MC, "Topical use of hydroquinone for depigmentation", JAMA, 194, pp.962~964 (1965)
32. Ennes SB, "A double-blind, comparative, placebo-controlled study of the efficacy and tolerability of 4% hydroquinone as a depigmenting agent in melasma", J Dermatolog Treat, 11, pp.173~179 (2000)
33. Westerhof W, "Hydroquinone and its analogues in dermatology-a potential health risk", J Cosmet Dermatol, 4, pp.55~59 (2005)
34. Mishra SN, "Diagnostic utility of dermatoscopy in hydroquinone-induced exogenous ochronosis", Int J Dermatol, 52, pp.413~417 (2013)
35. Kwon SH, "Melasma : updates and perspectives", Exp Dermatol, 28, pp.704~708 (2019)
36. Ortonne JP, "Retinoid therapy of pigmentary disorders", Dermatol Ther, 19, pp.280~288 (2006)
37. Griffiths CE, "Topical tretinoin(retinoic acid)improves melasma. A vehicle-controlled, clinical trial", Br J Dermatol, 129, pp.415~421 (1993)
38. Sheth VM, "Melasma : a comprehensive update : part II", J Am Acad Dermatol, 65, pp.699~714 (2011)
39. Dogra S, "Adapalene in the treatment of melasma : a preliminary report", J Dermatol, 29, pp.539~540 (2002)
40. Taylor SC, "Efficacy and safety of a new triple-combination agent for the treatment of facial melasma", Cutis, 72, pp.67~72 (2003)
41. Ferreira Cestari T, "A comparison of triple combination cream and hydroquinone 4% cream for the treatment of moderate to severe facial melasma", J Cosmet Dermatol, 6, pp.36~39 (2007)
42. Lynde CB, "Topical treatments for melasma and postinflammatory hyperpigmentation", Skin Therapy Lett, 11, pp.1~6 (2006)
43. Ishack S, "Exogenous ochronosis associated with hydroquinone : a systematic review", Int J Dermatol, 61, pp.675~684 (2022)
44. Ahmad Nasrollahi S, "Evaluation of the safety and efficacy of a triple combination cream(hydroquinone, tretinoin, and fluocinolone)for treatment of melasma in Middle Eastern skin", Clin Cosmet Investig Dermatol, 12, pp.437~444 (2019)
45. Yi X, "MITF-siRNA formulation is a safe and effective therapy for human melasma", Mol Ther, 19, pp.362~371 (2011)
46. Matsui MS, "Omeprazole, a gastric proton pump inhibitor, inhibits melanogenesis by blocking ATP7A trafficking", J Invest Dermatol, 135, pp.834~841 (2015)
47. Shin JM, "Proton pump inhibitors as a possible cause of vitiligo : an in vivo and in vitro study", J Eur Acad Dermatol Venereol, 28, pp.1475~1479 (2014)
48. Kasraee B, "Topical methimazole as a new treatment for postinflammatory hyperpigmentation : report of the first case", Dermatology, 211, pp.360~362 (2005)
49. Kasraee B, "Safety of topical methimazole for the treatment of melasma. Transdermal absorption, the effect on thyroid function and cutaneous adverse effects", Skin Pharmacol Physiol, 21, pp.300~305 (2008)
50. Maeda K, "Mechanism of the inhibitory effect of tranexamic acid on melanogenesis in cultured human melanocytes in the presence of keratinocyte-conditioned medium", J Health Sci, 53, pp.389~396 (2007)
51. Cho YH, "Tranexamic acid inhibits melanogenesis by activating the autophagy system in cultured melanoma cells", J Dermatol Sci, 88, pp.96~102 (2017)
52. Murase D, "Autophagy has a significant role in determining skin color by regulating melanosome degradation in keratinocytes", J Invest Dermatol, 133, pp.2416~2424 (2013)
53. Karn D, "Oral tranexamic acid for the treatment of melasma", Kathmandu Univ Med J, 10, pp.40~43 (2012)
54. Del Rosario E, "Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma", J Am Acad Dermatol, 78, pp.363~369 (2018)
55. Minni K, "Efficacy and safety of oral tranexamic acid as an adjuvant in Indian patients with melasma: a prospective, interventional, single-centre, triple-blind, randomized, placebo-control, parallel group study", J Eur Acad Dermatol Venereol, 34, pp.2636~2644 (2020)
56. Lajevardi V, "Comparison of the therapeutic efficacy and safety of combined oral tranexamic acid and topical hydroquinone 4% treatment vs. topical hydroquinone 4% alone in melasma : a parallel-group, assessor-and analyst-blinded, randomized controlled trial with a short-term follow-up", J Cosmet Dermatol, 16, pp.235~242 (2017)
57. Zhu CY, "Analysis of the effect of different doses of oral tranexamic acid on melasma : a multicentre prospective study", Eur J Dermatol, 29, pp.55~58 (2019)
58. Cho HH, "Role of oral tranexamic acid in melasma patients treated with IPL and low fluence QS Nd : YAG laser", J Dermatolog Treat, 24, pp.292~296 (2013)
59. Shin JU, "Oral tranexamic acid enhances the efficacy of low-fluence 1064-nm quality-switched neodymium-doped yttrium aluminum garnet laser treatment for melasma in Koreans : a randomized, prospective trial", Dermatol Surg, 39, pp.435~442 (2013)
60. Kanechorn Na Ayuthaya P, "Topical 5% tranexamic acid for the treatment of melasma in Asians : a double-blind randomized controlled clinical trial", J Cosmet Laser Ther, 14, pp.150~154 (2012)
61. Ebrahimi B, "Topical tranexamic acid as a promising treatment for melasma", J Res Med Sci, 19, pp.753~757 (2014)
62. Xu Y, "Efficacy of func¬tional microarray of microneedles combined with topical tranexamic acid for melasma: a randomized, self-controlled, split-face study", Medicine(Baltimore), 96, pp.e6897~ (2017)
63. Mekawy KM, "Micro-needling versus fractional carbon dioxide laser for delivery of tranexamic acid in the treatment of melasma : a split-face study", J Cosmet Dermatol, 20, pp.460~465 (2021)
64. Tawfic SO, "Assessment of combined fractional CO2 and tranexamic acid in melasma treatment", Lasers Surg Med, 51, pp.27~33 (2019)
65. Lee JH, "Localized intradermal microinjection of tranexamic acid for treatment of melasma in Asian patients : a preliminary clinical trial", Dermatol Surg, 32, pp.626~631 (2006)
66. Nestor M, "Polypodium leucotomos as an adjunct treatment of pigmentary disorders", J Clin Aesthet Dermatol, 7, pp.13~17 (2014)
67. González S, "Inhibition of ultraviolet-induced formation of reactive oxygen species, lipid peroxidation, erythema and skin photosensitization by polypodium leucotomos", Photodermatol Photoimmunol Photomed, 12, pp.45~56 (1996)
68. Gomes AJ, "The antioxidant action of Polypodium leucotomos extract and kojic acid : reactions with reactive oxygen species", Braz J Med Biol Res, 34, pp.1487~1494 (2001)
69. Hayakawa R, "Effects of combination treatment with vitamins E and C on chloasma and pigmented contact dermatitis. A double blind controlled clinical trial", Acta Vitaminol Enzymol, 3, pp.31~38 (1981)
70. Handog EB, "A randomized, double-blind, placebo-controlled trial of oral procyanidin with vitamins A, C, E for melasma among Filipino women", Int J Dermatol, 48, pp.896~901 (2009)
71. Yamakoshi J, "Oral intake of proanthocyanidin-rich extract from grape seeds improves chloasma", Phytother Res, 18, pp.895~899 (2004)
72. Song M, "Korean red ginseng powder in the treatment of melasma : an uncontrolled observational study", J Ginseng Res, 35, pp.170~175 (2011)
73. Teo W, "Double blind placebo controlled trial to evaluate of the effectiveness of a dietary supplement rich in carotenoids as adjunct to topical lightening cream for the treatment of melasma : a pilot study", J Pigment Disord, 2, pp.1000164~ (2015)
74. Ni Z, "Treatment of melasma with Pycnogenol", Phytother Res, 16, pp.567~571 (2002)
75. Sarkar R, "Chemical peels in melasma : a review with consensus recommendations by Indian Pigmentary Expert Group", Indian J Dermatol, 62, pp.578~584 (2017)
76. Sarkar R, "Comparative evaluation of efficacy and tolerability of glycolic acid, salicylic mandelic acid, and phytic acid combination peels in melasma", Dermatol Surg, 42, pp.384~391 (2016)
77. Lim JT, "Glycolic acid peels in the treatment of melasma among Asian women", Dermatol Surg, 23, pp.177~179 (1997)
78. Hurley ME, "Efficacy of glycolic acid peels in the treatment of melasma", Arch Dermatol, 138, pp.1578~1582 (2002)
79. Sarkar R, "The combination of glycolic acid peels with a topical regimen in the treatment of melasma in dark-skinned patients : a comparative study", Dermatol Surg, 28, pp.828~832 (2002)
80. Dayal S, "Combination of glycolic acid peel and topical 20% azelaic acid cream in melasma patients : efficacy and improvement in quality of life", J Cosmet Dermatol, 16, pp.35~42 (2017)
81. Wang CC, "Intense pulsed light for the treatment of refractory melasma in Asian persons", Dermatol Surg, 30, pp.1196~1200 (2004)
82. Yun WJ, "A prospective, split-face, randomized study of the efficacy and safety of a novel fractionated intense pulsed light treatment for melasma in Asians", J Cosmet Laser Ther, 17, pp.259~266 (2015)
83. Tong LG, "Combination of fractional QSRL and IPL for melasma treatment in Chinese population", J Cosmet Laser Ther, 19, pp.13~17 (2017)
84. Ogbechie-Godec OA, "an up-to-date comprehensive review", Dermatol Ther(Heidelb), 7, pp.305~318 (2017)
85. Hassan AM, "Pulsed dye laser versus intense pulsed light in melasma : a split-face comparative study", J Dermatolog Treat, 29, pp.725~732 (2018)
86. Mun JY, "A low fluence Q-switched Nd:YAG laser modifies the 3D structure of melanocyte and ultrastructure of melanosome by subcellular-selective photothermolysis", J Electron Microsc(Tokyo), 60, pp.11~18 (2011)
87. Kim T, "Punctate leucoderma after 1, 064-nm Q-switched neodymium-doped yttrium aluminum garnet laser with low-fluence therapy : is it melanocytopenic or melanopenic?", Dermatol Surg, 36, pp.1790~1791 (2010)
88. Feng J, "Comparison of picosecond and nanosecond Nd : YAG 1064-nm lasers in the treatment of melasma : a split-face randomized clinical trial", Plast Reconstr Surg, 151, pp.772~777 (2023)
89. Kim JC, "Skin-aging pigmentation : who is the real enemy?", Cells, 11, pp.2541~ (2022)
90. Cameli N, "Combined use of monopolar radiofrequency and transdermal drug delivery in the treatment of melasma", Dermatol Surg, 40, pp.748~755 (2014)
91. Lolis MS, "Radiofrequency in cosmetic dermatology : a review", Dermatol Surg, 38, pp.1765~1776 (2012)
92. Jung JW, "A face-split study to evaluate the effects of microneedle radiofrequency with Q-switched Nd : YAG laser for the treatment of melasma", Ann Dermatol, 31, pp.133~138 (2019)
93. Choi M, "Successful treatment of refractory melasma using invasive micro-pulsed electric signal device", Med Lasers, 4, pp.39~44 (2015)
94. Kim HM, "Therapeutic efficacy and safety of invasive pulsed-type bipolar alternating current radiofrequency on melasma and rebound hyperpigmentation", Med Lasers, 6, pp.17~23 (2017)
95. Phansuk K, "Dermal pathology in melasma : an update review", Clin Cosmet Investig Dermatol, 15, pp.11~19 (2022)
96. Gilchrest BA, "Treatment of photodamage with topical tretinoin : an overview", J Am Acad Dermatol, 36, pp.S27~S36 (1997)

관련 논문AI추천